Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Intranasal Versus Intravenous Dexamethasone to Treat Hospitalized COVID-19 Patients: A Randomized Multicenter Clinical Trial.
Cárdenas G, Chávez-Canales M, Espinosa AM, Jordán-Ríos A, Malagon DA, Murillo MFM, Araujo LVT, Campos RLB, Wong-Chew RM, González LER, Cresencio KI, Velázquez EG, de la Cerda MR, Leyva Y, Hernández-Ruiz J, Hernández-Medel ML, León-Hernández M, Quero KM, Monciváis AS, Sarmiento EB, Reynoso RIA, Reyes DM, Del Río Ambriz LR, Hernández JSG, Cruz J, Ferrer SIV, Huerta L, Fierro NA, Hernández M, Pérez-Tapia M, Meneses G, Rosas G, Hernández-Aceves JA, Cervantes-Torres J, Valdez RA, Rodríguez AF, Espíndola-Arriaga E, Ortiz M, Salazar EA, Barba CC, Besedovsky H, Romano MC, Jung H, Bobes RJ, Soldevila G, López-Alvarenga JC, Fragoso G, Laclette JP, Sciutto E. Cárdenas G, et al. Among authors: hernandez medel ml. Arch Med Res. 2024 Feb;55(2):102960. doi: 10.1016/j.arcmed.2024.102960. Epub 2024 Jan 29. Arch Med Res. 2024. PMID: 38290199 Clinical Trial.
Intranasal dexamethasone: a new clinical trial for the control of inflammation and neuroinflammation in COVID-19 patients.
Cárdenas G, Chávez-Canales M, Espinosa AM, Jordán-Ríos A, Malagon DA, Murillo MFM, Araujo LVT, Campos RLB, Wong-Chew RM, González LER, Cresencio KI, Velázquez EG, de la Cerda MR, Leyva Y, Hernández-Ruiz J, Hernández-Medel ML, León-Hernández M, Quero KM, Monciváis AS, Díaz SH, Martínez IRZ, Martínez-Cuazitl A, Salazar INM, Sarmiento EB, Peña AF, Hernández PS, Reynoso RIA, Reyes DM, Del Río Ambriz LR, Bonilla RAA, Cruz J, Huerta L, Fierro NA, Hernández M, Pérez-Tapia M, Meneses G, Espíndola-Arriaga E, Rosas G, Chinney A, Mendoza SR, Hernández-Aceves JA, Cervantes-Torres J, Rodríguez AF, Alor RO, Francisco SO, Salazar EA, Besedovsky H, Romano MC, Bobes RJ, Jung H, Soldevila G, López-Alvarenga J, Fragoso G, Laclette JP, Sciutto E. Cárdenas G, et al. Among authors: hernandez medel ml. Trials. 2022 Feb 14;23(1):148. doi: 10.1186/s13063-022-06075-5. Trials. 2022. PMID: 35164840 Free PMC article. Clinical Trial.
Mucormycosis in the COVID-19 scenario beyond hospitalized patients.
Bonifaz A, Tirado-Sánchez A, Araiza J, Hernández-Medel ML. Bonifaz A, et al. Among authors: hernandez medel ml. Future Microbiol. 2023 Jan;18:5-8. doi: 10.2217/fmb-2022-0147. Epub 2023 Jan 17. Future Microbiol. 2023. PMID: 36648217 No abstract available.
Gram-negative ESKAPE bacteria bloodstream infections in patients during the COVID-19 pandemic.
Alcántar-Curiel MD, Huerta-Cedeño M, Jarillo-Quijada MD, Gayosso-Vázquez C, Fernández-Vázquez JL, Hernández-Medel ML, Zavala-Pineda M, Morales-Gil MÁ, Hernández-Guzmán VA, Bolaños-Hernández MI, Giono-Cerezo S, Santos-Preciado JI. Alcántar-Curiel MD, et al. Among authors: hernandez medel ml. PeerJ. 2023 Mar 29;11:e15007. doi: 10.7717/peerj.15007. eCollection 2023. PeerJ. 2023. PMID: 37013147 Free PMC article.
The Age-AST-D Dimer (AAD) Regression Model Predicts Severe COVID-19 Disease.
Higuera-de-la-Tijera F, Servín-Caamaño A, Reyes-Herrera D, Flores-López A, Robiou-Vivero EJA, Martínez-Rivera F, Galindo-Hernández V, Rosales-Salyano VH, Casillas-Suárez C, Chapa-Azuela O, Chávez-Morales A, Jiménez-Bobadilla B, Hernández-Medel ML, Orozco-Zúñiga B, Zacarías-Ezzat JR, Camacho S, Pérez-Hernández JL. Higuera-de-la-Tijera F, et al. Among authors: hernandez medel ml. Dis Markers. 2021 Mar 23;2021:6658270. doi: 10.1155/2021/6658270. eCollection 2021. Dis Markers. 2021. PMID: 33791045 Free PMC article.
Mucormycosis at a tertiary-care center in Mexico. A 35-year retrospective study of 214 cases.
Bonifaz A, Tirado-Sánchez A, Hernández-Medel ML, Araiza J, Kassack JJ, Del Angel-Arenas T, Moisés-Hernández JF, Paredes-Farrera F, Gómez-Apo E, Treviño-Rangel RJ, González GM. Bonifaz A, et al. Among authors: hernandez medel ml. Mycoses. 2021 Apr;64(4):372-380. doi: 10.1111/myc.13222. Epub 2020 Dec 13. Mycoses. 2021. PMID: 33253454
Telemedicine and humanization of medical care in the Covid-19 pandemic.
Sevilla-Fuente S, Hernández-Medel ML. Sevilla-Fuente S, et al. Among authors: hernandez medel ml. Salud Publica Mex. 2020 Sep-Oct;62(5):459-461. doi: 10.21149/11540. Epub 2020 Jul 15. Salud Publica Mex. 2020. PMID: 32697900 English. No abstract available.
Programa de microeliminación del virus de la hepatitis C en una población abierta.
Rodríguez-Fuentes E, Higuera-de la Tijera F, Hernández-Medel ML, Pérez-Hernández JL, Serrano-Loyola R, Guerrero-Avendaño GML. Rodríguez-Fuentes E, et al. Among authors: hernandez medel ml. Salud Publica Mex. 2023 Jul 15;65(4, jul-ago):320-321. doi: 10.21149/14814. Salud Publica Mex. 2023. PMID: 38060889 Spanish. No abstract available.
Antimicrobial resistance and antibiotic consumption in Mexican hospitals.
Miranda-Novales MG, Flores-Moreno K, López-Vidal Y, Rodríguez-Álvarez M, Solórzano-Santos F, Soto-Hernández JL, Ponce de León-Rosales S; UNCAR Network*. Miranda-Novales MG, et al. Salud Publica Mex. 2020 Jan-Feb;62(1):42-49. doi: 10.21149/10543. Salud Publica Mex. 2020. PMID: 31869560 English.